Drug research

Vehicle Cream

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)NCT04845620	ARQT	Phase 3	Completed	2023-06-01Actual
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNCT04773587	ARQT	Phase 3	Completed	2022-08-30Actual
INM-755 (Cannabinol) Cream for Treatment of Epidermolysis BullosaNCT04908215	INM	Phase 2	Completed	2023-04-03Actual

ARQTCompletedPrimary completion: 2023-06-01 · Actual

Trial details

ARQTCompletedPrimary completion: 2022-08-30 · Actual

Trial details

INMCompletedPrimary completion: 2023-04-03 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.